http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63166881-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c7159366be37ecf8a4c595cfa235a8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
filingDate 1986-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_630e3715a08aa4e1be62daf2baa06848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb2952adcf65ea06d9318e2c722bd161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c01dc55ce2bb83fc70abc10d0a09ebc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d31192ff3c7352eb0395bd5dcf3eebe
publicationDate 1988-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S63166881-A
titleOfInvention Aminoazaacridine derivative
abstract NEW MATERIAL:A compound expressed by formula I {R 1 WR 3 are H, halogen trifluoromethyl, lower alkyl, lower cycloalkyl, nitro, amino, (substituted)phenyl, etc.; R 4 is H, lower alkyl or (di)aralkyl, R 6 -CO- [R 6 is lower alkyl, lower cycloalkyl, (substituted)phenyl, etc.], etc.} or acid addition salt thereof. n EXAMPLE: 9-Amino-1,2,3,4-tetrahydro-1,4-ethano-1-azaacridine. n USE: Useful as a remedy for senile dementia having excellent inhibitory action on acetylcholine esterase. n PREPARATION: A 2-aminobenzonitrile derivative expressed by formula II, e.g. 2-amino-6-fluorobenzonitrile, etc., is reacted with a 3-quinuclidine expressed by formula III to afford the aimed compound expressed by formula I (group R 4 is H). n COPYRIGHT: (C)1988,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H032166-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0319232-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485840-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0319429-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1891954-A2
priorityDate 1986-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422760650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226451666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17814471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410441280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421125483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20092773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226527739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421127720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234603480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7527

Total number of triples: 35.